Atlas Trials

A Placebo-controlled Trial of Fractional Flow Reserve-guided Percutaneous Renal Artery Stenting Among Atherosclerosis Renal-vascular Hypertension Patients

Clinical trial NCT07111442 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07111442
Sponsor
Peking University First Hospital
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Renal Artery Stenosis AtheroscleroticSecondary Hypertension Renal Arterial
Start date
2025-08-30
Primary completion
2028-08-30
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.